Sudden infant death syndrome: No increased risk after immunisation

Abstract Background Although previous studies have shown either no association between immunisation and SIDS or even a decreased risk of SIDS, adverse effects, including death, from immunisations continue to cause concern, especially when a new vaccine is introduced. Methods A large case control stu...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2007-01, Vol.25 (2), p.336-340
Main Authors: Vennemann, M.M.T, Butterfaß-Bahloul, T, Jorch, G, Brinkmann, B, Findeisen, M, Sauerland, C, Bajanowski, T, Mitchell, E.A
Format: Article
Language:English
Subjects:
Allergy and Immunology
Applied microbiology
Babies
Biological and medical sciences
Case control study
Fundamental and applied biological sciences. Psychology
Humans
Immunisation
Immunization - adverse effects
Infant
Infant, Newborn
Microbiology
Mortality
Risk Factors
SIDS
Standard mortality rate
Sudden Infant Death - etiology
Sudden infant death syndrome
Vaccines
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background Although previous studies have shown either no association between immunisation and SIDS or even a decreased risk of SIDS, adverse effects, including death, from immunisations continue to cause concern, especially when a new vaccine is introduced. Methods A large case control study with immunisation data on 307 SIDS cases and 971 controls. Results SIDS cases were immunised less frequently and later than controls. Furthermore there was no increased risk of SIDS in the 14 days following immunisation. There was no evidence to suggest the recently introduced hexavalent vaccines were associated with an increased risk of SIDS. Conclusions This study provides further support that immunisations may reduce the risk of SIDS.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2006.07.027